A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer

NCT05574712 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Principal Investigator has decided not to activate this trial.

Conditions

Prostate Cancer

Interventions

DRUG: Neoadjuvant treatment

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins